335 related articles for article (PubMed ID: 23630573)
1. Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria.
Wilson NO; Solomon W; Anderson L; Patrickson J; Pitts S; Bond V; Liu M; Stiles JK
PLoS One; 2013; 8(4):e60898. PubMed ID: 23630573
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.
Solomon W; Wilson NO; Anderson L; Pitts S; Patrickson J; Liu M; Ford BD; Stiles JK
J Neuroinflammation; 2014 Jan; 11():9. PubMed ID: 24433482
[TBL] [Abstract][Full Text] [Related]
3. Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model.
Dormoi J; Briolant S; Pascual A; Desgrouas C; Travaillé C; Pradines B
Malar J; 2013 Aug; 12():302. PubMed ID: 23988087
[TBL] [Abstract][Full Text] [Related]
4. The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative.
Dai M; Freeman B; Bruno FP; Shikani HJ; Tanowitz HB; Weiss LM; Reznik SE; Stephani RA; Desruisseaux MS
Life Sci; 2012 Oct; 91(13-14):687-92. PubMed ID: 22820174
[TBL] [Abstract][Full Text] [Related]
5. Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria.
Du Y; Chen G; Zhang X; Yu C; Cao Y; Cui L
Int Immunopharmacol; 2017 Jul; 48():219-230. PubMed ID: 28531845
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model.
Souraud JB; Briolant S; Dormoi J; Mosnier J; Savini H; Baret E; Amalvict R; Soulard R; Rogier C; Pradines B
Malar J; 2012 Jan; 11():13. PubMed ID: 22233563
[TBL] [Abstract][Full Text] [Related]
7. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
8. Impact of methylene blue and atorvastatin combination therapy on the apparition of cerebral malaria in a murine model.
Dormoi J; Briolant S; Desgrouas C; Pradines B
Malar J; 2013 Apr; 12():127. PubMed ID: 23587099
[TBL] [Abstract][Full Text] [Related]
9. Artemether and artesunate show the highest efficacies in rescuing mice with late-stage cerebral malaria and rapidly decrease leukocyte accumulation in the brain.
Clemmer L; Martins YC; Zanini GM; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2011 Apr; 55(4):1383-90. PubMed ID: 21220531
[TBL] [Abstract][Full Text] [Related]
10. Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4/AKT/STAT3 signaling.
Liu M; Solomon W; Cespedes JC; Wilson NO; Ford B; Stiles JK
J Neuroinflammation; 2018 Apr; 15(1):104. PubMed ID: 29636063
[TBL] [Abstract][Full Text] [Related]
11. Heme mediated STAT3 activation in severe malaria.
Liu M; Amodu AS; Pitts S; Patrickson J; Hibbert JM; Battle M; Ofori-Acquah SF; Stiles JK
PLoS One; 2012; 7(3):e34280. PubMed ID: 22479586
[TBL] [Abstract][Full Text] [Related]
12. From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.
Yalcin O; Oronsky B; Carvalho LJ; Kuypers FA; Scicinski J; Cabrales P
Malar J; 2015 May; 14():218. PubMed ID: 26017006
[TBL] [Abstract][Full Text] [Related]
13. Plasma IP-10, apoptotic and angiogenic factors associated with fatal cerebral malaria in India.
Jain V; Armah HB; Tongren JE; Ned RM; Wilson NO; Crawford S; Joel PK; Singh MP; Nagpal AC; Dash AP; Udhayakumar V; Singh N; Stiles JK
Malar J; 2008 May; 7():83. PubMed ID: 18489763
[TBL] [Abstract][Full Text] [Related]
14. Inhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malaria.
Serghides L; Kim H; Lu Z; Kain DC; Miller C; Francis RC; Liles WC; Zapol WM; Kain KC
PLoS One; 2011; 6(11):e27714. PubMed ID: 22110737
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of artesunate combined with Atractylodes lancea or Prabchompoothaweep remedy extracts as adjunctive therapy for the treatment of cerebral malaria.
Plirat W; Chaniad P; Phuwajaroanpong A; Konyanee A; Viriyavejakul P; Septama AW; Punsawad C
BMC Complement Med Ther; 2023 Sep; 23(1):332. PubMed ID: 37730604
[TBL] [Abstract][Full Text] [Related]
16. IL-4 Treatment Mitigates Experimental Cerebral Malaria by Reducing Parasitemia, Dampening Inflammation, and Lessening the Cytotoxicity of T Cells.
Wu X; Thylur RP; Dayanand KK; Punnath K; Norbury CC; Gowda DC
J Immunol; 2021 Jan; 206(1):118-131. PubMed ID: 33239419
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of angiopoietin-1 plays a mechanistic role in the pathogenesis of cerebral malaria.
Higgins SJ; Purcell LA; Silver KL; Tran V; Crowley V; Hawkes M; Conroy AL; Opoka RO; Hay JG; Quaggin SE; Thurston G; Liles WC; Kain KC
Sci Transl Med; 2016 Sep; 8(358):358ra128. PubMed ID: 27683553
[TBL] [Abstract][Full Text] [Related]
18. S1P is associated with protection in human and experimental cerebral malaria.
Finney CA; Hawkes CA; Kain DC; Dhabangi A; Musoke C; Cserti-Gazdewich C; Oravecz T; Liles WC; Kain KC
Mol Med; 2011; 17(7-8):717-25. PubMed ID: 21556483
[TBL] [Abstract][Full Text] [Related]
19. CXCL4 and CXCL10 predict risk of fatal cerebral malaria.
Wilson NO; Jain V; Roberts CE; Lucchi N; Joel PK; Singh MP; Nagpal AC; Dash AP; Udhayakumar V; Singh N; Stiles JK
Dis Markers; 2011; 30(1):39-49. PubMed ID: 21508508
[TBL] [Abstract][Full Text] [Related]
20. A novel carbon monoxide-releasing molecule fully protects mice from severe malaria.
Pena AC; Penacho N; Mancio-Silva L; Neres R; Seixas JD; Fernandes AC; Romão CC; Mota MM; Bernardes GJ; Pamplona A
Antimicrob Agents Chemother; 2012 Mar; 56(3):1281-90. PubMed ID: 22155828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
